Cell Growth & Differentiation, Vol 5, Issue 3 329-340, Copyright © 1994 by American Association of Cancer Research

ARTICLES

Tumor-promoting phorbol ester transiently down-modulates the p53 level and blocks the cell cycle

J Skouv, PO Jensen, J Forchhammer, JK Larsen and LR Lund
Department of Molecular Oncology, Danish Cancer Society, Copenhagen.

Activation of the protein kinase C signaling pathway by tumor-promoting phorbol esters, such as 4 beta-phorbol 12-myristate 13-acetate (PMA), induced a decrease in the level of p53 mRNA in several serum-starved human cell lines. Also, the tumor-promoting phosphatase inhibitor okadaic acid induced a decrease in the p53 mRNA level in the cell lines. Normal diploid as well as various tumor cell lines were tested. Two tumor cell lines, HeLa and A549, both containing the wild-type p53 gene, but very different levels of p53 protein, were studied in detail. In both cell lines, the level of p53 mRNA was minimal after 9 h of exposure to PMA. After approximately 120 h, the p53 mRNA level was similar to the pretreatment level. PMA induced a similar transient decrease in the level of p53 protein in the A549 cell line. The decrease in the p53 mRNA level could not be explained by changes in the transcriptional rate or the p53 mRNA stability. The protein synthesis inhibitor cycloheximide completely abolished the PMA-induced down-modulation of the p53 mRNA, suggesting that a short-lived protein was involved in the down-modulation. Flow cytometric cell cycle analysis showed that the phorbol ester treatment induced a block in the late G1 phase. The blockage was transient, and its duration correlated with the level of p53 protein in the two cell lines. We propose that the protein kinase C-catalyzed phosphorylation of p53 may be a key event in the down-modulation of p53 expression as well as in the induced blockage of the cell cycle.

This article has been cited by other articles:

				T. Abbas, D. White, L. Hui, K. Yoshida, D. A. Foster, and J. Bargonetti Inhibition of Human p53 Basal Transcription by Down-regulation of Protein Kinase C{delta} J. Biol. Chem., March 12, 2004; 279(11): 9970 - 9977. [Abstract] [Full Text] [PDF]

				J. S. Rasey, J. R. Grierson, L. W. Wiens, P. D. Kolb, and J. L. Schwartz Validation of FLT Uptake as a Measure of Thymidine Kinase-1 Activity in A549 Carcinoma Cells J. Nucl. Med., September 1, 2002; 43(9): 1210 - 1217. [Abstract] [Full Text] [PDF]

				K. Chylicki, M. Ehinger, H. Svedberg, G. Bergh, I. Olsson, and U. Gullberg p53-mediated Differentiation of the Erythroleukemia Cell Line K562 Cell Growth Differ., June 1, 2000; 11(6): 315 - 324. [Abstract] [Full Text]

				G. J. Milczarek, W. Chen, A. Gupta, J. D. Martinez, and G.T. Bowden Okadaic acid mediates p53 hyperphosphorylation and growth arrest in cells with wild-type p53 but increases aberrant mitoses in cells with non-functional p53 Carcinogenesis, June 1, 1999; 20(6): 1043 - 1048. [Abstract] [Full Text] [PDF]

				C. Asiedu, J. Biggs, and A. S. Kraft Complex Regulation of CDK2 During Phorbol Ester-Induced Hematopoietic Differentiation Blood, November 1, 1997; 90(9): 3430 - 3437. [Abstract] [Full Text] [PDF]

				T. R. Hupp and D. P. Lane Two Distinct Signaling Pathways Activate the Latent DNA Binding Function of p53 in a Casein Kinase II-independent Manner J. Biol. Chem., July 28, 1995; 270(30): 18165 - 18174. [Abstract] [Full Text] [PDF]

				T.R. Hupp and D.P. Lane Regulation of the Cryptic Sequence-specific DNA-binding Function of p53 by Protein Kinases Cold Spring Harb Symp Quant Biol, January 1, 1994; 59(0): 195 - 206. [Abstract] [PDF]